发明名称 Agents directed against a cis RGMa/Neogenin interaction or lipid rafts and use of the same in methods of treatment
摘要 Disclosed herein is an agent that modulates a cis interaction between Repulsive Guidance Molecule A (RGMa) and Neogenin or lipid rafts. Modulation by the agent may include blocking the cis interaction between RGMa and Neogenin and/or disrupting lipid rafts. In turn, this promotes neuronal cell survival and axon growth and/or regeneration. Also disclosed herein is a method of treating a disease in a subject in need thereof. The method may include administering the agent to the subject. Further disclosed herein is a method of identifying an agent that modulates the cis interaction between RGMa and Neogenin.
申请公布号 AU2014324043(A1) 申请公布日期 2016.03.17
申请号 AU20140324043 申请日期 2014.08.06
申请人 UNIVERSITY HEALTH NETWORK (UHN): TECHNOLOGY DEVELOPMENT AND COMMERCIALIZATION 发明人 MONNIER, PHILIPPE P.;TASSEW, NARDOS G.
分类号 C07K14/705;A61K31/137;A61K38/17;A61K39/395;A61P9/10;A61P25/00;C07K14/435;G01N33/53 主分类号 C07K14/705
代理机构 代理人
主权项
地址